EWM
Essex Woodlands Management Portfolio holdings
AUM $279M
1-Year Return
29.39%
This Quarter Return
-26.39%
1 Year Return
+29.39%
3 Year Return
+195.65%
5 Year Return
+90.32%
10 Year Return
+273.6%
AUM
$155M
AUM Growth
-$59.1M
(-28%)
Cap. Flow
+$2.34M
Cap. Flow
% of AUM
1.51%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
TELA Bio
TELA
|
+$2.38M |
Top Sells
| 1 |
MediciNova
MNOV
|
+$42.5K |
Sector Composition
| 1 | Healthcare | 99.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
1
DELISTED
Revance Therapeutics, Inc.
RVNC
| $49.5M | 31.84% |
3,342,047
| – | – |
|
2
EyePoint Pharmaceuticals
EYPT
$924M
| $42.7M | 27.52% |
4,190,922
| – | – |
|
3
Axogen
AXGN
$753M
| $25.3M | 16.27% |
2,429,999
| – | – |
|
4
Venus Concept
VERO
$4.24M
| $24.9M | 16.04% |
42,532
| – | – |
|
|
5
TELA Bio
TELA
$62.6M
| $8.4M | 5.41% |
1,074,231
+305,000
| +40% | +$2.38M |
|
|
6
MediciNova
MNOV
$60.8M
| $4.11M | 2.65% |
1,105,941
-11,414
| -1% | -$42.5K |
|
7
Gyre Therapeutics
GYRE
$718M
| $344K | 0.22% |
10,483
| – | – |
|
|
ELGX
8
DELISTED
Endologix Inc
ELGX
| $89K | 0.06% |
125,747
| – | – |
|